Supplementary Methods, Figures 1 - 2 from ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 TherapyFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Supplementary methods from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Supplementary Methods, Figures 1 - 2 from ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 TherapyFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Supplementary methods from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0